^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

methylprednisolone acetate

Associations
Company:
Generic mfg.
Drug class:
GCR agonist
Associations
8d
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression (clinicaltrials.gov)
P3, N=150, Recruiting, Hospital for Special Surgery, New York | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Dec 2026
Trial completion date • Trial primary completion date
|
methylprednisolone acetate
1m
Conservative Treatment in Patients With Supraspinatus Tendon Injury. (clinicaltrials.gov)
P=N/A, N=40, Recruiting, Medical University of Lodz | Trial primary completion date: Jul 2025 --> May 2026
Trial primary completion date
|
methylprednisolone acetate
2ms
Hoffa's Fat Pad Impingement (HFPI) (clinicaltrials.gov)
P=N/A, N=62, Not yet recruiting, Boston Children's Hospital
New trial
|
methylprednisolone acetate • octreotide acetate
8ms
Trial completion
|
methylprednisolone acetate
8ms
Yale SEVEN: Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2 (clinicaltrials.gov)
P2, N=66, Recruiting, Yale University | Trial completion date: Mar 2026 --> Mar 2028 | Trial primary completion date: Mar 2025 --> Sep 2027
Trial completion date • Trial primary completion date
|
dexamethasone • methylprednisolone acetate
8ms
Yale SEVEN: Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study (clinicaltrials.gov)
P2, N=250, Recruiting, Yale University | Trial completion date: Mar 2026 --> Mar 2028 | Trial primary completion date: Mar 2025 --> Sep 2027
Trial completion date • Trial primary completion date
|
dexamethasone • methylprednisolone acetate
9ms
The Use of Intra-articular Corticosteroid Injection to Treat Osteoarthritis of the Carpometacarpal Joint (clinicaltrials.gov)
P4, N=90, Active, not recruiting, University of Alberta | Recruiting --> Active, not recruiting
Enrollment closed
|
methylprednisolone acetate
10ms
ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial (clinicaltrials.gov)
P=N/A, N=45, Active, not recruiting, Arthrex, Inc. | Recruiting --> Active, not recruiting | Trial primary completion date: May 2025 --> Aug 2025
Enrollment closed • Trial primary completion date
|
methylprednisolone acetate
11ms
Post-operative Methylprednisolone Taper Course for Orthopedic Surgery (clinicaltrials.gov)
P4, N=500, Enrolling by invitation, Emory University | N=1000 --> 500 | Trial completion date: Jan 2025 --> Jan 2029 | Trial primary completion date: Jan 2025 --> Jan 2029
Enrollment change • Trial completion date • Trial primary completion date
|
dexamethasone injection • methylprednisolone acetate • methylprednisolone oral
12ms
The Use of Intra-articular Corticosteroid Injection to Treat Osteoarthritis of the Carpometacarpal Joint (clinicaltrials.gov)
P4, N=90, Recruiting, University of Alberta | Trial completion date: Dec 2024 --> Dec 2025 | Trial primary completion date: Dec 2024 --> Dec 2025
Trial completion date • Trial primary completion date
|
methylprednisolone acetate
12ms
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression (clinicaltrials.gov)
P3, N=150, Recruiting, Hospital for Special Surgery, New York | Trial completion date: Dec 2024 --> Dec 2025 | Trial primary completion date: Dec 2024 --> Dec 2025
Trial completion date • Trial primary completion date
|
methylprednisolone acetate
1year
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma (clinicaltrials.gov)
P1, N=30, Recruiting, Oncotherapeutics | Not yet recruiting --> Recruiting | Initiation date: Jan 2024 --> Dec 2022
Enrollment open • Trial initiation date
|
lenalidomide • Jakafi (ruxolitinib) • methylprednisolone acetate • methylprednisolone oral